Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2012.519 | An observational, multi-center, prospective, open-label study to assess the real-life treatment pattern for Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong and its adherence to GOLD guideline | Dr CHAN Hok Sum, Christopher |
| 2011.010 | The management pattern,co-morbidities and morbidity of COPD patients in HK | Dr Chan Hok Sum |
| 2012.304 | Therapeutic hypothermia after cardiac arrest: a survey of practice in ICUs in Hong Kong | Dr Chan Hok Sum |
| 2014.555 | Disease Burden of Chronic Obstructive Pulmonary Disease of in-patients in the Hospital Authority in Hong Kong - the Trend from 2006 - 2014 | Dr. CHAN Hok Sum |
| 2014.300 | Hong Kong Hospital Authority Lung Abscess Audit | Dr. CHAN Hok Sum |
| 2014.294 | Patient Registry of Roflumilast In Real Life-Division of North Asia | Dr. CHAN Hok Sum |
| 2011.279 | Continuous Quality Improvement: Use of Lean Techniques to Improve Patient Flow in Emergency Department | Ms. Chan Hoi Yan |
| 2010.273 | Correlational Study on catastrophizing and Patient Functioning - the Buffering role of value among Breast Cancer Patients | Ms CHAN Hoi Sze Gloria |
| 2010.269 | Correlational Study on Catastrophizing and Patient Functioning - the Buffering Role of value among Lung Cancer Patients | Ms CHAN Hoi Sze Gloria |
| 2014.004 | A cross-sectional study examines the relationships between perceived and actual physical competence, enjoyment and physical activity in Primary School children. | Ms Chan Hoi Sze Cecilica |
| 2022.248 | Psychoeducation with active participation for enhancing caregiving self-efficacy among family caregivers of people with dementia: a feasibility trial |
Ms. CHAN Hoi Man 陳海雯 |
| 2023.168 | Pictorial Review of Breast Augmentations and Their Complications | Dr. CHAN Hoi Ling |
| 2023.236 | DECT special application in MSK : Case Series | Dr. CHAN Hoi Ling |
| 2023.169 | Breast Intraductal Papilloma Diagnosed by Core Needle Biopsy: Prognosis of Vacuum-assisted Excision, Surgical Excision or Follow-up USG | Dr. CHAN Hoi Ling |
| 2023.207 | Transcatheter Arterial Embolization of Renal Angiomyolipoma Using Ethanol and Lipiodol | Dr. CHAN Hoi Ling |
| 2019.695 | A prospective pilot study on the effectiveness of MEDFRAT in reducing falls in Hong Kong Emergency Department |
Miss CHAN Ho Yi 陳可宜 |
| 2018.049 | Improving workflow of Emergency Medicine Ward (EMW) admission process in North District Hospital (NDH) by using self-administered health assessment form |
Miss CHAN Ho Yi 陳可宜 |
| 2019.532 | Evaluation of the effectiveness of acupuncture at L.I.11 Quchi acupoint on knee pain in Hong Kong distance runners: A randomized controlled trial |
Ms. Chan Ho Yan 陳可昕 |
| 2011.350 | Study of the system performance of cobas 8000 clinical chemistry analyzer in a hospital-based clinical laboratory | Dr CHAN Ho Ming, Michael |
| 2011.427 | Survelliance of emerging drugs of abuse in substance abusers | Dr CHAN Ho Ming Michael |
| 2013.007 | Determination of optimal holotranscobalamin diagnostic cutoff for vitamin B12 deficiency in local Chinese population - a clinical laboratory evaluation study | Dr. Chan Ho Ming Michael |
| 2023.540 | Effectiveness of MSK Occupational Therapy Program in treating patients with shoulder pain |
Mr. CHAN Ho Man 陳昊旻 |
| 2021.626 | Prevalence and determinants of neonatal jaundice in Hong Kong: A population-based, retrospective analysis |
Dr. CHAN Hiu Ying 陳曉瑩 |
| 2019.668 | Association between hospital admission episode and use of potentially inappropriate medication in geriatric patient according to Beers Criteria: a Hong Kong local hospital experience | Ms. CHAN Hiu Ching |
| 2009.447 | A case series observational study on the clinical application of a surgical robot in otorhinolaryngology, head and neck surgery compared to historical controls | Dr Chan Hing Sang |
| 2015.083 | Patient Knowledge of Inflammatory Bowel Disease in Area of Rising Incidence |
Dr. CHAN Heyson Chi Hey 陳智曦 |
| 2016.113 | Incidence of venous thromboembolism in inflammatory bowel disease patients in Asia |
Dr. CHAN Heyson Chi Hey 陳智曦 |
| 2013.406 | Comparison of upper GI involvement of asymptomatic Crohn's disease patients in Europe and Asia | Dr. CHAN Heyson Chi Hey |
| 2011.525 | Colorectal Cancer Screening in Diabetes Patients: A case-control Study (DM Colon Study) | Dr. Chan Heyson |
| 2009.105 | A Single-arm, Multinational, Two Year Study Evaluating the Efficacy and Safety of Lead-in Telbivudine for 24 Weeks with or without Tenofovir Treatment Intensification in Adult Patients with HBeAg-positive Chronic Hepatitis B | Professor Chan Henry Lik-Yuen |
| 2013.156 | A multi-centre 3-year follow-up study to assess the durability of sustained virologic response in Alisporivir-treated chronic Hepatitis C patients | Prof. Chan Henry Lik-Yuen |
| 2009.250 | A randomized, open-label, controlled, exploratory trial to characterize the results of daily oral administration of telbivudine 600mg and tenofovir disproxil fumarate 300mg in combination or telbivudine 600mg or tenofovir disproxil furmarate 300mg monothe | Professor Chan Henry Lik-Yuen |
| 2008.164 | Effect of Alcohol and Caffeine on the Severity of Liver Fibrosis in Chronic Hepatitis B | Prof Chan Henry Lik-Yuen |
| 2010.093 | Genetic Variation in IL28B and the response to peginterferon treatment in patients with chronic hepatitis B | Dr Chan Henry Lik-Yuen |
| 2013.694 | Genetic Study of Peginterferon Treatment in Hepatitis B: The GIANT -B Study | Prof. CHAN Henry Lik Yuen |
| 2019.233 | CATALYST 207: A PHASE 2, PILOT, EXPLORATORY STUDY EVALUATING THE SAFETY AND ANTIVIRAL EFFICACY OF INARIGIVIR SOPROXIL IN NON-CIRRHOTIC TREATMENT-NAÏVE SUBJECTS INFECTED WITH CHRONIC HEPATITIS B VIRUS | Prof. CHAN Henry Lik Yuen |
| 2019.151 | A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GS-4224 in Healthy Volunteers and Subjects with the Chronic Hepatitis B (CHB) Virus |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2014.354 | Performance of Fibrometer™ S and V in Chinese patients with non alcoholic fatty liver disease (NAFLD) | Prof. CHAN Henry Lik Yuen |
| 2014.488 | A Phase 1b Dose-Ranging Study to Assess the Safety, Pharmacokinetics and Initial Antiviral Efficacy of NVR 3-778 in Patients with HBeAg-Positive, Chronic Hepatitis B Virus Infection | Dr. CHAN Henry Lik Yuen |
| 2017.270 | A RANDOMIZED, SPONSOR-OPEN, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS ADMINISTRATION OF RO7062931 WITH SINGLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND MULTIPLE DOSES AND MODIFIED REGIMENS IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2014.658 | A Phase IIB-III, open-label, randomized, comparative study to assess the efficacy of ABX203 to maintain control of Hepatitis B disease after cessation of treatment with nucleos(t)ide analogs in adult HBeAg negative patients with chronic Hepatitis B in the Asia Pacific region | Prof. CHAN Henry Lik Yuen |
| 2016.034 | A Multicenter, Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Combination with Entecavir or Tenofovir in Patients with Chronic Hepatitis B Virus (HBV) Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2014.415 | Prospective Sample Collection - Evaluation of novel markers for early detection of Hepatocellular Carcinoma (HCC) - | Prof. CHAN Henry Lik Yuen |
| 2014.668 | An Open Label Study of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection | Prof. CHAN Henry Lik Yuen |
| 2016.529 | Cells of monocytic origin as surrogate marker for individual drug effects and hepatotoxicity |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2017.198 | A SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY STUDY OF RO7049389 IN: (1) SINGLE- (WITH OR WITHOUT FOOD) AND MULTIPLE- (WITH MIDAZOLAM) ASCENDING DOSES IN HEALTHY VOLUNTEERS; (2) PATIENTS CHRONICALLY INFECTED WITH HEPATITIS B VIRUS (3) PATIENTS WITH CHRONIC HEPATITIS B |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2014.416 | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic HCV | Prof. CHAN Henry Lik Yuen |
| 2015.190 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination with Entecavir or Tenofovir in Patients with HBeAg Positive, Chronic Hepatitis B Virus (HBV) Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
| 2017.530 | A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) in Virologically Suppressed Chronic Hepatitis B Subjects with Renal and/or Hepatic Impairment |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2015.189 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination with Entecavir or Tenofovir in Patients with HBeAg Negative, Chronic Hepatitis B Virus (HBV) Infection |
Prof. CHAN Henry Lik Yuen 陳力元教授 |
Page 198 of 254.